CVS / CIRCULATORY SYSTEM
HEART CARE
ARJUN CHHAL/CHURNA POWDER
ARJUNARISHTA/PARTHADYARISHTA
LOHASAVA
MUKTAAVATI
VITCOFOL drps
IMFERON Liq.
TONOFERRON Drps
FERROCHELATE DRPS
HAEMATINGA DRPS
VIMAGNA LIQ.
DEXORANGE LIQ.
Sorbitrate 5/10 Tab.
Nifedipine 5/10 Tab.
Ecosprin 75/150 Tab.
FERROHIT LIQ.
COLD,FEVER,COUGH ETC.
Liq. FEBREX PLUS / SINAREST
Liq. CLAVUM
Liq. CHESTON EXPECTORANT
Liq. VISYNERAL
Liq. Calpol
Liq. Nise / Nimulid
Liq. Pacimol /Cofamol
Liq. WILORYL
Liq. Fevril
Liq. Pronim (Nimesulide )
Liq. Lemolinctus (cold,cough)
Liq. Lemo (Montelukast +Levocetrizine )
Liq. COLDACT
Liq. Zyrcold (ZyrCold is a combination of two medicines: Cetirizine and Ambroxol, which relieves cough. Cetirizine is an antiallergic that treats runny nose, watery eyes and sneezing. Ambroxol is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out and clears)
Liq. Spicold (Spicold 125 mg/12.5 mg/1 mg Suspension is a combination of three medicines: Paracetamol, Phenylpropanolamine and Chlorpheniramine Maleate which relieve cold symptoms. Paracetamol is an analgesic (pain reliever) and antipyretic (fever reducer)
Liq. Coscold (Paracetamol, Caffeine, Diphenhydramine, and Phenylephrine)
Liq. CHESTON COLD (Cheston Cold Tablet is a combination of three medicines: Cetirizine, Paracetamol and Phenylephrine, which relieves common cold symptoms.)
Liq. Rinostat (Paracetamol, Chlorpheniramine Maleate and Pseudoephedrine which relieve common cold symptoms. Paracetamol is an analgesic (pain reliever) and antipyretic (fever reducer).
Liq. SUDAFED (The syrup contains pseudoephedrine hydrochloride, which is a decongestant that relieves nasal and sinus congestion Company: McNeil Consumer Healthcare)
Liq. ACTIFED PLUS (Actifed Plus Tablet is a combination of three medicines: Paracetamol, Pseudoephedrine and Triprolidine, which relieves cold symptoms.)
Liq. PHENARGAN plus. (Phenergan Plus Syrup contains two active ingredients: paracetamol, and promethazine. These ingredients together relieve common cold symptoms. Promethazine is an antiallergic that relieves allergy symptoms like runny nose, watery eyes, and sneezing.)
Liq. Synabran Expectorant (Bromhexine, Salbutamol and Guaifenesin)
Liq. Dilosyn Expectorant (Methdilazine, ammonium chloride and sodium citrate which relieve cough. Methdilazine is an antiallergic which relieves allergy symptoms like runny nose, watery eyes and sneezing.)
Liq. ALVIKOF PLUS
Liq. LEVOCETRIZIN+MONTELUKAST
NASIVION Drps
NASOCLEAR Drps
Liq. MONOCEF O 50/100 (CEFPODOXIME PROXETIL)
Liq. MACPOD CV 50/100 (CEFPODOXIME PROXETIL+CLA)
Liq. MOXIKIND CV 375 (AMOXY+CLAUV)
Liq. CEFADUR 125/250 (CEFADROXIL)
The content present in Droxyl 500 is cefadroxil as its main component. It is an antibiotic used to treat bacterial infections of the urinary tract, throat, lungs, airways and skin caused by various susceptible organisms.
Liq. ZIFI 50/100 (CEFIXIME)
Liq. CEFUROXIME
Liq. CEPHALEXIN
Liq. CEFACLOR ( Eclor 125 Liq. / Eclor La 375Mg Tablet is used for treating bacterial infections including pneumonia, bronchitis, exacerbations of chronic bronchitis, pharyngitis, tonsillitis, sinusitis, otitis media, skin and soft tissue infections, urinary tract infections such as pyelonephritis and cystitis.)
Liq. AMOXYCILLIN (Liq. MOX)
Liq. AMPICILLIN+CLOXACILLIN)
Tab. PENTIDS 400,800U (PENICILLINS)
Liq. CLARITHROMYCIN
Liq. CLINDAMYCIN
Liq. LINCOMYCIN
Liq. AZITHROMYCIN
Liq. ERYTHROMYCIN
Liq. ROXITHROMYCIN
Liq. OFLOXACIN
Liq. OFLOXACIN+CEFIXIME
Liq. OFLOXACIN+ORNIDAZOLE
Liq. OFLOXACIN+METRONIDAZOLE
Liq. METRONIDAZOLE+TINIDAZOLE
Liq. DEFLAZACORT
Liq. FLUZET X (Fluzet Suspension is a combination of four medicines: Chlorpheniramine, dextromethorphan, paracetamol and phenylephrine which relieve dry cough.)
Liq. SYNABRAN EXPECTORANT (Synabron Expectorant is a combination of four medicines: Bromhexine, Guaifenesin, Menthol and Salbutamol. Bromhexine is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out.)
Each 5 mL of syrup contains guaifenesin 50 mg and salbutamol (as sulfate) 1 mg. It also contains the following excipients: Hydroxypropyl methylcellulose, sodium benzoate, saccharin sodium, lactic acid, orange flavour (IFF 17.40. 0095), mint essence, silica, maize starch and purified water
Liq. CHERIKOF
Liq. TUSPEL PLUS
Liq. ETOSALBETOL
Liq. DERIPHYLLIN
Liq. Salmodil (Salmodil Plus Syrup is a combination of three medicines: Guaifenesin, Terbutaline and Bromhexine, which relieves cough with mucus. Guaifenesin is an expectorant which decreases the stickiness of mucus (phlegm) and helps in its removal from the airways. Terbutaline is a bronchodilator)
Liq. TIXYLYX
Liq. LYNX
Liq. SYNCLAR
BREATHLESSNESS PNEUMONIA
URTI LRTI
Inj. TRAXOL/MONOCEF 250/500/1
(CEFTRIAXONE SODIUM) 12hrly
Inj. DERIPHYLLIN
Inj. DEXA
Inj. AMIKACIN 250/500 IV 12hrly
Liq. MONOCEF O
Liq. CLAVUM
Liq. DEFLAZACORT
Liq. TUSPEL PLUS
Liq. FEBREX PLUS
Clindamycin is used to treat certain types of bacterial infections, including infections of the lungs, skin, blood, female reproductive organs, and internal organs. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria.
LINCOMYCIN
LYNX LIQUID 60ML is used in the treatment of bacterial infections of the ear, nose, throat, respiratory tract, gastrointestinal tract, biliary tract, bone and joint, skin and soft tissue, furuncles (boils), secondary wound infections, gynaecological infection and sepsis (blood poisoning.
Lynx 125 mg Suspension is an antibiotic medicine containing lincomycin.
IMMUNISATION SCHEDULE
Overview
While immunization is one of the most successful public health interventions, coverage has plateaued over the last decade. The COVID-19 pandemic and associated disruptions have strained health systems, with 25 million children missing out on vaccination in 2021, 5.9 million more than in 2019 and the highest number since 2009.
During 2021, about 81% of infants worldwide (105 million infants) received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine, protecting them against infectious diseases that can cause serious illness and disability or be fatal.
Twenty five vaccine introductions were reported in 2021 (not including COVID-19 vaccine introductions). Although this is an increase from 17 introductions in 2020, it is well below the number of introductions of any year in the past two decades prior to 2020. This slowdown is likely to continue as countries focus on ongoing efforts to control the COVID-19 pandemic.
A summary of global vaccination coverage in 2021 follows.
Haemophilus influenzae type b (Hib) causes meningitis and pneumonia. Hib vaccine had been introduced in 192 Member States by the end of 2021. Global coverage with 3 doses of Hib vaccine is estimated at 71%. There is great variation between regions. The WHO Eastern Mediterranean Region and South-East Asia Region are each estimated to have 82% coverage, while it is only 29% in the WHO Western Pacific Region.
Hepatitis B is a viral infection that attacks the liver. Hepatitis B vaccine for infants had been introduced nationwide in 190 Member States by the end of 2021. Global coverage with 3 doses of hepatitis B vaccine is estimated at 80%. In addition, 111 Member States introduced nationwide 1 dose of hepatitis B vaccine to newborns within the first 24 hours of life. Global coverage is 42% and is as high as 78% in the WHO Western Pacific Region, while it is only estimated to be at 17% in the WHO African Region.
Human papillomavirus (HPV) is the most common viral infection of the reproductive tract and can cause cervical cancer in women, other types of cancer, and genital warts in both men and women. Including 5 new introductions, 116 Member States have introduced HPV vaccine by the end of 2021. Since many large countries have not yet introduced the vaccine and vaccine coverage decreased in 2021 in many countries, global coverage with the first dose of HPV among girls is now estimated at 15%. This is a proportionally large reduction from 20% in 2019.
Meningitis A is an infection that is often deadly and leaves 1 in 5 affected individuals with long-term devastating sequelae. Before the introduction of MenAfriVac in 2010 – a revolutionary vaccine – meningitis serogroup A accounted for 80–85% of meningitis epidemics in the African meningitis belt. By the end of 2021, 350 million people in 24 out of the 26 countries in the meningitis belt had been vaccinated with MenAfriVac through campaigns. Thirteen countries had included MenAfriVac in their routine immunization schedule by 2021..
Measles is a highly contagious disease caused by a virus, which usually results in a high fever and rash, and can lead to blindness, encephalitis or death. By the end of 2021, 81% of children had received 1 dose of measles-containing vaccine by their second birthday, and 183 Member States had included a second dose as part of routine immunization and 71% of children received 2 doses of measles vaccine according to national immunization schedules.
Mumps is a highly contagious virus that causes painful swelling at the side of the face under the ears (the parotid glands), fever, headache and muscle aches. It can lead to viral meningitis. Mumps vaccine had been introduced nationwide in 123 Member States by the end of 2021.
Pneumococcal diseases include pneumonia, meningitis and febrile bacteraemia, as well as otitis media, sinusitis and bronchitis. Pneumococcal vaccine had been introduced in 154 Member States by the end of 2021, including 2 in some parts of the country, and global third dose coverage was estimated at 51%. There is great variation between regions. The WHO European Region is estimated to have 82% coverage, while it is only 19% in the WHO Western Pacific Region.
Polio is a highly infectious viral disease that can cause irreversible paralysis. In 2021, 80% of infants around the world received 3 doses of polio vaccine. In 2021, the coverage of infants receiving their first dose of inactivated polio vaccine (IPV) in countries that are still using oral polio vaccine (OPV) is estimated at 79%. Targeted for global eradication, polio has been stopped in all countries except for Afghanistan and Pakistan. Until poliovirus transmission is interrupted in these countries, all countries remain at risk of importation of polio, especially vulnerable countries with weak public health and immunization services and travel or trade links to endemic countries.
Rotaviruses are the most common cause of severe diarrhoeal disease in young children throughout the world. Rotavirus vaccine was introduced in 118 countries by the end of 2021, including 2 in some parts of the country. Global coverage was estimated at 49%.
Rubella is a viral disease which is usually mild in children, but infection during early pregnancy may cause fetal death or congenital rubella syndrome, which can lead to defects of the brain, heart, eyes and ears. Rubella vaccine was introduced nationwide in 173 Member States by the end of 2021, and global coverage was estimated at 66%.
Tetanus is caused by a bacterium which grows in the absence of oxygen, for example in dirty wounds or the umbilical cord if it is not kept clean. The spores of C. tetani are present in the environment irrespective of geographical location. It produces a toxin which can cause serious complications or death. Maternal and neonatal tetanus persist as public health problems in 12 countries, mainly in Africa and Asia.
Yellow fever is an acute viral haemorrhagic disease transmitted by infected mosquitoes. As of 2021, yellow fever vaccine had been introduced in routine infant immunization programmes in 36 of the 40 countries and territories at risk for yellow fever in Africa and the Americas. In these 40 countries and territories, coverage is estimated at 47%.
